Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan D Lünemann

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Science Immunology|June 5, 2026
Rogue clones: When MS autoimmunity goes viralJan D Lünemann
Neurology|December 14, 2011
Epstein-Barr virus in multiple sclerosis: a continuing conundrumJan D Lünemann
Nature Reviews. Neurology|November 28, 2024
Moving beyond immunoglobulin therapy for CIDP with efgartigimodJan D Lünemann
Nature Reviews. Neurology|August 24, 2021
Getting specific: targeting Fc receptors in myasthenia gravisJan D Lünemann
FEBS Letters|April 14, 2011
Environmental triggers of multiple sclerosisKristina Kakalacheva, Jan D Lünemann
Neurology|May 22, 2009
Immune responses to EBNA1: biomarkers in MS?Jan D Lünemann, Alberto Ascherio
Trends in Immunology|May 12, 2009
EBV in MS: guilty by association?Jan D Lünemann, Christian Münz
Current Neurology and Neuroscience Reports|May 10, 2007
Epstein-Barr virus and multiple sclerosisJan D Lünemann, Christian Münz
Journal of Clinical Immunology|April 25, 2014
Fc glycan-modulated immunoglobulin G effector functionsIsaak Quast, Jan D Lünemann
Brain : a Journal of Neurology|July 1, 2008
Do natural killer cells accelerate or prevent autoimmunity in multiple sclerosis?Jan D Lünemann, Christian Münz
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Science Immunology|June 5, 2026
Rogue clones: When MS autoimmunity goes viralJan D Lünemann
Neurology|December 14, 2011
Epstein-Barr virus in multiple sclerosis: a continuing conundrumJan D Lünemann
Nature Reviews. Neurology|November 28, 2024
Moving beyond immunoglobulin therapy for CIDP with efgartigimodJan D Lünemann
Nature Reviews. Neurology|August 24, 2021
Getting specific: targeting Fc receptors in myasthenia gravisJan D Lünemann
FEBS Letters|April 14, 2011
Environmental triggers of multiple sclerosisKristina Kakalacheva, Jan D Lünemann
Neurology|May 22, 2009
Immune responses to EBNA1: biomarkers in MS?Jan D Lünemann, Alberto Ascherio
Trends in Immunology|May 12, 2009
EBV in MS: guilty by association?Jan D Lünemann, Christian Münz
Current Neurology and Neuroscience Reports|May 10, 2007
Epstein-Barr virus and multiple sclerosisJan D Lünemann, Christian Münz
Journal of Clinical Immunology|April 25, 2014
Fc glycan-modulated immunoglobulin G effector functionsIsaak Quast, Jan D Lünemann
Brain : a Journal of Neurology|July 1, 2008
Do natural killer cells accelerate or prevent autoimmunity in multiple sclerosis?Jan D Lünemann, Christian Münz
Pageof 15